The 100 most-cited articles in Parkinson’s disease
Parkinson’s disease (PD), the second most common neurodegenerative disease, has serious clinical effects. Research on PD is increasing, but the quantity and quality of this research have not been reported.
To analyze the most-cited articles on PD and provide information about developments in this field, we searched for articles in the Web of Science for the keyword “Parkinson*” in the title. We selected the 100 most-cited articles and evaluated information including citation number, publication time, journal, impact factor, authors, original country, institution of corresponding author, and study type.
Citation numbers for the 100 most-cited articles ranged from 669 to 6902, with a median of 944. The 100 articles were published from 1967 to 2009, with most appearing between 1996 and 2000 (n = 24) and 2001 to 2005 (n = 27). The publications appeared in a total of 31 journals, led by Science with 15 and the New England Journal of Medicine (NEJM) with 13. The majority (84%) of the 100 most-cited articles had ≥ 3 authors. The articles originated from 14 countries, led by the USA (n = 44) and England (n = 17). Among the 100 most-cited articles, 24 were clinical studies, 54 were laboratory studies, 20 were reviews, and 2 were clinical guidelines. None of these articles originated from South America, Oceania, or Africa.
The present study provides historical perspectives on the progress of PD research and highlights trends and academic achievements in this field.
KeywordsMost-cited Parkinson’s disease Neurodegenerative diseases
This work was supported by the Bureau of Education of Jiangxi province (150972, GJJ13686), Health Department of Jiangxi Provincial (20122032). De-qing Cai would like to thank the Health and Family Planning Commission of Jiangxi Province (20175559). We are grateful for the efforts of Yuan-hui Liu, MD, of the Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong General Hospital, Guangzhou 510100, China.
Compliance with ethical standards
Conflict of interest